No Data
Perrigo Company Plc (PRGO): Leading OTC Health Products With Strong Growth in Infant Formula
Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024
Biden, Harris Propose Free OTC Contraception Under ACA
J.P. Morgan Maintains Perrigo(PRGO.US) With Buy Rating, Cuts Target Price to $38
Perrigo Company (PRGO) Receives a Buy From J.P. Morgan
Express News | Perrigo Company PLC : JP Morgan Cuts Target Price to $38 From $41